Results 171 to 180 of about 240,300 (249)

T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy. [PDF]

open access: yesJ Immunother Cancer
Bear HD   +20 more
europepmc   +1 more source

STIL overexpression shortens lifespan and reduces tumor formation in mice. [PDF]

open access: yesPLoS Genet
Moussa AT   +10 more
europepmc   +1 more source

Stil

open access: yes, 1932
openaire   +1 more source

Home - About - Disclaimer - Privacy